BeStock  
Stocks › Medical Devices › LIVN

LivaNova LIVN

US equityMarket cap rank #2056Medical DevicesBrain-Computer Interface
$90.73 −$1.34 (-1.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $90.73 0.00%
Open$91.50
Prev close$92.07
Day range$90.15 – $93.16
Volume536.7K
Market cap$5.00B
P/E (TTM)26.0
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$393.15M+9.9% YoY
Operating profit$28.43M-47.4% YoY
Net profit$34.29M+28.0% YoY
Diluted EPS$0.11-77.6% YoY
Free cash flow$42.89M-31.0% YoY
Operating cash flow$73.66M

Revenue, last 8 quarters

$321.8MDec '24$316.9MMar '25$352.5MJun '25$357.8MSep '25$360.9MDec '25$362.3MMar '26$390.6MJun '26$393.1MSep '26

Net profit, last 8 quarters

$55.9MDec '24$-327.3MMar '25$27.2MJun '25$26.8MSep '25$30.9MDec '25$22.3MMar '26$108.6MJun '26$34.3MSep '26

Diluted EPS by quarter

1.02Dec '24-6.01Mar '250.50Jun '250.49Sep '250.56Dec '250.40Mar '261.93Jun '260.11Sep '26

Free cash flow by quarter

$68.3MDec '24$13.2MMar '25$47.8MJun '25$62.2MSep '25$50.2MDec '25$926.0KMar '26$35.0MJun '26$42.9MSep '26

Annual revenue

$934.2MFY20$1.0BFY21$1.0BFY22$1.2BFY23$1.3BFY24$1.4BFY25

Profitability & balance sheet

Gross margin67.8%
Operating margin10.7%
Net margin13.0%
Return on equity15.5%
Return on assets7.4%
Return on invested capital12.2%
Current ratio1.46
Liabilities / assets49.4%
Cash & investments$563.47M
Total debt$347.88M
Net cash (debt)$215.58M
Free cash flow / sales8.6%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Cardiopulmonary$225.30M 57.3%
  • Neuromodulation$166.13M 42.3%
  • Other revenue$1.72M 0.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $393.15M $390.59M $362.26M $1.39B $360.92M
Total Operating Revenue $393.15M $390.59M $362.26M $1.39B $360.92M
Cost of Revenue $128.10M $116.92M $118.51M $448.18M $121.15M
Gross Profit $265.05M $273.67M $243.75M $939.87M $239.77M
Operating Expense $236.63M $224.19M $202.28M $740.48M $197.20M
Selling and Admin Expenses $154.93M $158.13M $143.57M $548.81M $143.37M
Research & Development $47.69M $53.66M $58.70M $185.76M $52.12M
Other Operating Expenses $34.01M $12.40M $15,000.00 $5.90M $1.71M
Operating Profit $28.43M $49.48M $41.47M $199.39M $42.58M
Net Non-Operating Interest Income (Expense) -$4.06M -$3.35M -$4.74M -$30.30M -$3.75M
Non-Operating Interest Income $3.90M $3.83M $3.55M $18.98M $4.46M
Non-Operating Interest Expense $7.95M $7.18M $8.29M $49.29M $8.21M
Other Income (Expense) $22.41M -$27.66M -$9.25M -$389.87M -$11.20M
Gain on Sale of Security $22.41M -$41.41M -$8.12M -$25.34M -$11.60M
Special Income (Charges) $0.00 $13.65M -$1.13M -$365.19M -$261,000.00
-Less:Write Off $0.00 $0.00 $1.13M $1.11M $0.00
Pretax Profit $46.77M $18.48M $27.49M -$220.78M $27.63M
Tax $12.40M -$90.20M $4.34M $21.64M -$3.28M
$84,000.00 $114,000.00 $851,000.00 $51,000.00 $10,000.00
Net Profit $34.29M $108.57M $22.29M -$242.47M $30.91M
Profit from Continuing Operations $34.29M $108.57M $22.29M -$242.47M $30.91M
Net Income to Parent Company $34.29M $108.57M $22.29M -$242.47M $30.91M
Net Income to Common Stockholders $34.29M $108.57M $22.29M -$242.47M $30.91M
Basic EPS $0.62 $1.98 $0.41 -$4.45 $0.57
Diluted EPS $0.11 $1.93 $0.40 -$4.45 $0.56
-Gain on Sale of Property/Plant/Equipment – $13.65M – $4.13M –
Other Non-Operating Income (Expenses) – $105,000.00 – $664,000.00 –
-Less:Impairment of Capital Assets – – – $0.00 –
-Less:Other Special Charges – – – $368.20M $4.39M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.71B $2.64B $2.52B $2.61B $2.61B
Total Current Assets $1.08B $1.03B $1.01B $1.10B $1.10B
Cash and Cash Equivalents & Short-Term Investments $563.47M $516.62M $539.71M $635.55M $635.55M
-Cash and Cash Equivalents $563.47M $516.62M $539.71M $635.55M $635.55M
Receivables $282.65M $274.17M $270.55M $264.59M $264.59M
-Accounts Receivable $236.37M $231.30M $229.27M $215.99M $215.99M
-Taxes Receivable $46.27M $42.87M $41.27M $48.61M $48.61M
Inventory $177.88M $172.61M $165.50M $164.70M $164.70M
Other Current Assets $58.85M $61.64M $38.48M $36.77M $36.77M
Total Non-Current Assets $1.63B $1.62B $1.50B $1.50B $1.50B
Net PPE $350.00M $330.05M $310.02M $298.12M $298.12M
-Gross PPE $350.00M $330.05M $310.02M $540.33M $540.33M
Investments and Advances $16.80M $15.27M $18.49M $20.29M $20.29M
Financial Assets $52.59M $57.29M $38.28M $36.55M $36.55M
Goodwill and Other Intangible Assets $989.54M $996.15M $1.01B $1.02B $1.02B
-Goodwill $778.81M $779.14M $785.59M $792.84M $792.84M
-Other Intangible Assets $210.73M $217.00M $224.56M $229.96M $229.96M
Non-Current Deferred Assets $194.45M $198.75M $109.82M $110.98M $110.98M
Other Non-Current Assets $26.90M $18.31M $15.37M $15.69M $15.69M
Total Liabilities $1.34B $1.32B $1.31B $1.41B $1.41B
Total Current Liabilities $740.19M $707.00M $762.48M $808.07M $808.07M
Payables $137.75M $127.41M $140.85M $130.29M $130.29M
-Accounts Payable $106.91M $103.39M $99.15M $97.16M $97.16M
-Total Tax Payable $30.84M $24.01M $41.70M $33.13M $33.13M
Current Accrued Expenses $72.28M $75.25M $72.52M $68.85M $68.85M
Short-Term Debt and Capital Lease Obligation $13.08M $12.37M $11.59M $40.26M $40.26M
-Current Debt $3.90M $3.58M $2.63M $31.47M $31.47M
-Current Capital Lease Obligation $9.19M $8.79M $8.96M $8.79M $8.79M
Current Provisions $31.73M $24.07M $14.01M $17.87M $17.87M
Current Deferred Liabilities $13.64M $13.86M $16.20M $11.51M $11.51M
Other Current Liabilities $383.79M $385.08M $449.69M $446.37M $446.37M
Total Non-Current Liabilities $600.86M $608.54M $542.55M $597.99M $597.99M
Long Term Debt and Capital Lease Obligation $343.99M $339.58M $331.86M $393.51M $393.51M
-Long Term Debt $295.19M $289.91M $285.16M $345.19M $345.19M
-Long Term Capital Lease Obligation $48.79M $49.67M $46.70M $48.33M $48.33M
Derivative Product Liabilities $124.75M $152.90M $93.25M $83.90M $83.90M
Non-Current Deferred Liabilities $7.74M $9.31M $6.81M $9.59M $9.59M
Employee Benefits $13.90M $13.97M $13.11M $13.57M $13.57M
Other Non-Current Liabilities $110.47M $92.77M $97.52M $97.41M $97.41M
Total Equity $1.37B $1.33B $1.21B $1.20B $1.20B
Stockholders' Equity $1.37B $1.33B $1.21B $1.20B $1.20B
Capital Stock $84.60M $84.60M $84.56M $84.56M $84.56M
-Common Stock $84.60M $84.60M $84.56M $84.56M $84.56M
Additional Paid-In Capital $2.28B $2.27B $2.25B $2.25B $2.25B
Retained Earnings -$980.56M -$1.01B -$1.12B -$1.15B -$1.15B
Less: Treasury Stock -$694,000.00 -$732,000.00 -$1.17M -$1.17M -$1.17M
Gains/Losses Not Affecting Retained Earnings -$15.25M -$14.39M -$3.40M $7.33M $7.33M
Restricted Cash – – – $0.00 $0.00
-Accumulated Depreciation – – – -$242.21M -$242.21M
-Available for Sale Securities – – – $3.00M $3.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $73.66M $66.59M $15.22M $254.34M $82.40M
Net cash flow from continuing operations $73.66M $66.59M $15.22M $254.34M $82.40M
Net Income from Continuing Operations $34.29M $108.57M $22.29M -$242.47M $30.91M
Gain/Loss from Continuing Operations -$22.82M $29.63M $9.80M -$8.38M $5.96M
Depreciation & Depletion & Amortization $17.79M $18.20M $15.60M $59.63M $14.71M
Deferred Tax $3.05M -$91.77M $1.82M $455,000.00 -$3.61M
Other Non-Cash Items $8.97M $3.31M $16.60M $34.10M $8.95M
Change in Working Capital -$11.15M -$18.23M -$60.29M $369.97M $19.13M
-Change in Receivables -$5.34M -$2.48M -$14.67M -$10.71M -$4.88M
-Change in Inventory -$5.28M -$8.60M -$1.55M -$5.29M $2.81M
-Change in Payables and Accrued Expense $15.63M -$4.55M -$37.06M -$17.04M $32.59M
-Change in Other Current Assets -$8.33M -$13.25M -$4.20M $38.54M -$12.04M
-Change in Other Current Liabilities $0.00 $0.00 $0.00 $365.55M $1.74M
Net cash flow from investing -$23.11M -$31.92M -$14.58M -$72.91M -$30.26M
Net Cash Flow from Continuing Investing Activities -$23.11M -$31.92M -$14.58M -$72.91M -$30.26M
Net PPE Purchase and Sale -$30.77M -$31.55M -$14.29M -$81.05M -$32.23M
Net Investment Purchase and Sale $6.95M – – $857,000.00 -$5.67M
Net Other Investing Changes $712,000.00 -$367,000.00 -$290,000.00 $7.28M $7.64M
Financing Cash Flow -$2.92M -$56.45M -$94.25M -$285.66M -$62.88M
Net Cash Flow from Continuing Financing Activities -$2.92M -$56.45M -$94.25M -$285.66M -$62.88M
Net Issuance Payments Of Debt $0.00 $0.00 -$95.94M -$280.93M -$64.11M
Net Other Financing Charges $8.81M -$56.45M $1.69M -$338,000.00 $2.00M
Ending Cash Balance $563.47M $516.62M $539.71M $635.55M $635.55M
Net Change in Cash $47.64M -$21.78M -$93.61M -$104.23M -$10.75M
Beginning Cash Balance $516.62M $539.71M $635.55M $723.56M $646.08M
Effect of Exchange Rate Changes -$788,000.00 -$1.31M -$2.24M $16.23M $219,000.00
Free Cash Flow $42.89M $35.04M $926,000.00 $173.29M $50.16M
-Change In Other Working Capital – $10.66M -$2.82M -$1.09M –
Proceeds from Stock Option Exercised – – – -$4.40M -$770,000.00

Discussion

No comments yet — be the first to weigh in on LIVN.

Sign in to join the discussion.

Scroll to Top